Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Pulmonary/Respiratory Diseases | Vaccines | Infections and Infectious Diseases
 Disease Category: Influenza
Location: United States, MO

Trial Information

Influenza Study

A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents with Acute Uncomplicated

The Dybedal Clinical Research Center is conducting a clinical trial to study the safety and effectiveness of an investigational medication in treating uncomplicated influenza, better known as the flu. All study procedures will be done at no cost. Participants will receive compensation for time and travel. For more information, visit the study's pages at clinicaltrials.gov

Duration: 28 days (outpatient)

Patient Inclusion Criteria:

  • 18-65 years; have a fever of at least 100.4 and are experiencing flu symptoms (fever, stuffy nose, cough, sore throat, fatigue, or headaches).

Patient Exclusion Criteria:

  • Severity of illness requiring or anticipated to require in- hospital care
  • Persons infected with Human Immunodeficiency Virus (HIV)
  • Known sensitivity to Nitazoxanide

Kim Erickson, Coordinator
Dybedal Clinical Research Center
1750 Independence Ave
Kansas City, MO 64106
Phone: 816-283-2335 or 1-800-234-4847 x2335
Fax: 816-283-2376
Email: kderickson@kcumb.edu

View Map

Research Center Information: Dybedal Clinical Research Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.